Antithymocyte Globulin, Clofarabine, and Rituximab in Treating Patients After an Unsuccessful Stem Cell Transplant
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Cancer
Interventions: BIOLOGICAL: anti-thymocyte globulin|BIOLOGICAL: rituximab|DRUG: clofarabine|PROCEDURE: stem cell transplantation
Sponsor: Masonic Cancer Center, University of Minnesota